Results 311 to 320 of about 102,686 (380)

Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay. [PDF]

open access: yesJ Neurol
Meda FJ   +11 more
europepmc   +1 more source

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis

open access: yesEuropean Journal of Neurology, Volume 33, Issue 2, February 2026.
ABSTRACT Background Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglia surface receptor that aids in tissue repair and debris clearance. The soluble form, sTREM2, found in both blood and cerebrospinal fluid, is considered a biomarker for microglial activation.
Nicolás Fissolo   +26 more
wiley   +1 more source

The Baraitser–Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β‐Actin Impairs Its Cellular Polymerization and Stability

open access: yesThe FASEB Journal, Volume 40, Issue 1, 15 January 2026.
BWCFF, a severe disease with neurological symptoms, is caused by mutations in the cytoskeletal actin genes. Patient‐derived fibroblasts carrying the R196H β‐actin mutation were compared to wild type cells. The mutant cells displayed slower proliferation and migration and a lower F‐actin content, which correlated with reduced cell stiffness ...
Éva Gráczer   +12 more
wiley   +1 more source

Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy. [PDF]

open access: yesJ Neurol
Lee S   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy